7951 - 7975 of 8808 Results
Title
Year
-
OPENTitle: Pink1 −/− Rats Show Early-Onset Swallowing Deficits and Correlative Brainstem PathologyJournal Name: DysphagiaPublisher: Springer Science and Business Media LLCVol: 33Issue #: 6Start Page: 749End Page: 758Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00455-018-9896-5Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6207473Citation Count: 42
-
OPENTitle: Connecting Gaucher and Parkinson Disease: Considerations for Clinical and Research Genetic Counseling SettingsJournal Name: Journal of Genetic CounselingPublisher: WileyVol: 26Issue #: 6Start Page: 1165End Page: 1172Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s10897-017-0123-6Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1007/s10897-017-0123-6Citation Count: 10
-
OPENTitle: Composite measures of motor performance and self-efficacy are better determinants of postural instability and gait difficulties than individual clinical measures in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 107Issue #:Start Page: 105251End Page: 105251Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.105251Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10028594/pdf/nihms-1882881.pdfCitation Count: 4
-
OPENTitle: Cholinergic Degeneration and Cognitive Function in Early GBA1‐Related Parkinson's DiseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 98Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/ana.27248Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.27248Citation Count: 0
-
OPENTitle: Genetic modulation of mitochondrial NAD+ regeneration does not prevent dopaminergic neuron dysfunction caused by mitochondrial complex I impairmentJournal Name: Frontiers in Cell and Developmental BiologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fcell.2025.1650462Best OA location URL: https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2025.1650462/pdfCitation Count: 0
-
OPENTitle: Pre-clinical therapeutic development of a series of metalloporphyrins for Parkinson's diseaseJournal Name: Toxicology and Applied PharmacologyPublisher: Elsevier BVVol: 326Issue #:Start Page: 34End Page: 42Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.taap.2017.04.004Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5704913Citation Count: 14
-
OPENTitle: The effect of polygenic risk score on PD risk and phenotype in LRRK2 G2019S and GBA1 carriersJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 15Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/1877718x241310722Best OA location URL: https://doi.org/10.1177/1877718x241310722Citation Count: 1
-
OPENTitle: RETRACTED: ESCRT-mediated Uptake and Degradation of Brain-targeted α-synuclein Single Chain Antibody Attenuates Neuronal Degeneration In VivoJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 22Issue #: 10Start Page: 1753End Page: 1767Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1038/mt.2014.129Best OA location URL: http://www.cell.com/article/S1525001616307808/pdfCitation Count: 82
-
OPENTitle: Single low doses of MPTP decrease tyrosine hydroxylase expression in the absence of overt neuron lossJournal Name: NeuroToxicologyPublisher: Elsevier BVVol: 60Issue #:Start Page: 99End Page: 106Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuro.2017.03.008Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5499677Citation Count: 43
-
RESTRICTEDTitle: Private variants in PRKN are associated with late-onset Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 75Issue #:Start Page: 24End Page: 26Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.05.003Citation Count: 6
-
RESTRICTEDTitle: Reinforcing properties of Pramipexole in normal and parkinsonian ratsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 49Issue #:Start Page: 79End Page: 86Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2012.08.005Best OA location URL: https://doaj.org/article/f2c79dbe00db45cd8b639599d5d6db7fCitation Count: 37
-
OPENTitle: High-Spatial-Resolution Diffusion MRI in Parkinson Disease: Lateral Asymmetry of the Substantia NigraJournal Name: RadiologyPublisher: Radiological Society of North America (RSNA)Vol: 291Issue #: 1Start Page: 149End Page: 157Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1148/radiol.2019181042Citation Count: 47
-
OPENTitle: LRRK2 Regulates Voltage-Gated Calcium Channel FunctionJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2016.00035Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2016.00035/pdfCitation Count: 54
-
OPENTitle: Cognitive behavioural therapy for anxiety disorders in Parkinson's disease: Design of a randomised controlled trial to assess clinical effectiveness and changes in cerebral connectivityJournal Name: Journal of Psychosomatic ResearchPublisher: Elsevier BVVol: 112Issue #:Start Page: 32End Page: 39Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jpsychores.2018.04.002Best OA location URL: https://cris.maastrichtuniversity.nl/en/publications/8d94b40b-cb36-4fd4-91a7-d6c0a3ffa5adCitation Count: 16
-
OPENTitle: Dual κ‐agonist/μ‐antagonist opioid receptor modulation reduces levodopa‐induced dyskinesia and corrects dysregulated striatal changes in the nonhuman primate model ofParkinson diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 77Issue #: 6Start Page: 930End Page: 941Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.24375Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6235675Citation Count: 49
-
OPENTitle: Stiripentol for the treatment of super-refractory status epilepticusJournal Name: Acta Neurologica ScandinavicaPublisher: WileyVol: 132Issue #: 6Start Page: 435End Page: 439Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ane.12403Best OA location URL: https://doi.org/10.1111/ane.12403Citation Count: 42
-
RESTRICTEDTitle: How specific are non-motor symptoms in the prodrome of Parkinson's disease compared to other movement disorders?Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 81Issue #:Start Page: 213End Page: 218Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.10.003Citation Count: 14
-
RESTRICTEDTitle: Transplant and risk of Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 63Issue #:Start Page: 149End Page: 155Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.013Citation Count: 6
-
OPENTitle: A person-centered approach to characterizing longitudinal ambulatory impairment in Parkinson's diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page: 11509End Page: 11509Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-024-62179-9Best OA location URL: https://www.nature.com/articles/s41598-024-62179-9.pdfCitation Count: 1
- In Situ Global Structural Proteome Analysis Identifies Potential Biomarkers for Parkinson's Disease2023OPENTitle: In Situ Global Structural Proteome Analysis Identifies Potential Biomarkers for Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 2Start Page: 198End Page: 198Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.29315Best OA location URL: https://doi.org/10.1002/mds.29315Citation Count: 2
-
OPENTitle: IntranasalNAP(davunetide) decreases tau hyperphosphorylation and moderately improves behavioral deficits in mice overexpressing α‐synucleinJournal Name: Pharmacology Research & PerspectivesPublisher: WileyVol: 2Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/prp2.65Best OA location URL: https://doi.org/10.1002/prp2.65Citation Count: 43
-
OPENTitle: Bridging a mechanistic gap from diet to synapsesJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 120Issue #: 33Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.2309992120Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10433296/pdf/pnas.202309992.pdfCitation Count: 1
-
OPENTitle: Environmental Risk Factors for Progressive Supranuclear PalsyJournal Name: Journal of Movement DisordersPublisher: The Korean Movement Disorder SocietyVol: 14Issue #: 2Start Page: 103End Page: 113Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.14802/jmd.20173Best OA location URL: https://doi.org/10.14802/jmd.20173Citation Count: 23
-
RESTRICTEDTitle: Regional cerebral cholinergic vesicular transporter correlates of visual contrast sensitivity in Parkinson's disease: Implications for visual and cognitive functionJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 131Issue #:Start Page: 107229End Page: 107229Publication Date:Open Access(OA) Status: RESTRICTEDLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107229Best OA location URL: https://doi.org/10.1016/j.parkreldis.2024.107229Citation Count: 2
-
OPENTitle: Reply to: Hypoxia treatment of Parkinson’s disease may disrupt the circadian systemJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 23Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-023-03281-9Best OA location URL: https://bmcneurol.biomedcentral.com/counter/pdf/10.1186/s12883-023-03281-9Citation Count: 0